150 related articles for article (PubMed ID: 8412206)
1. Oltipraz: a laboratory and clinical review.
Benson AB
J Cell Biochem Suppl; 1993; 17F():278-91. PubMed ID: 8412206
[TBL] [Abstract][Full Text] [Related]
2. Potent inhibition of aflatoxin-induced hepatic tumorigenesis by the monofunctional enzyme inducer 1,2-dithiole-3-thione.
Kensler TW; Groopman JD; Eaton DL; Curphey TJ; Roebuck BD
Carcinogenesis; 1992 Jan; 13(1):95-100. PubMed ID: 1346373
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of protection against aflatoxin tumorigenicity in rats fed 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (oltipraz) and related 1,2-dithiol-3-thiones and 1,2-dithiol-3-ones.
Kensler TW; Egner PA; Dolan PM; Groopman JD; Roebuck BD
Cancer Res; 1987 Aug; 47(16):4271-7. PubMed ID: 2886217
[TBL] [Abstract][Full Text] [Related]
4. Chronic daily low dose of 4-methyl-5-(2-pyrazinyl)-1,2-dithiole-3-thione (Oltipraz) in patients with previously resected colon polyps and first degree female relatives of breast cancer patients.
Benson AB; Olopade OI; Ratain MJ; Rademaker A; Mobarhan S; Stucky-Marshall L; French S; Dolan ME
Clin Cancer Res; 2000 Oct; 6(10):3870-7. PubMed ID: 11051232
[TBL] [Abstract][Full Text] [Related]
5. Intermittent dosing with oltipraz: relationship between chemoprevention of aflatoxin-induced tumorigenesis and induction of glutathione S-transferases.
Primiano T; Egner PA; Sutter TR; Kelloff GJ; Roebuck BD; Kensler TW
Cancer Res; 1995 Oct; 55(19):4319-24. PubMed ID: 7671242
[TBL] [Abstract][Full Text] [Related]
6. Chemoprotection by organosulfur inducers of phase 2 enzymes: dithiolethiones and dithiins.
Kensler TW; Curphey TJ; Maxiutenko Y; Roebuck BD
Drug Metabol Drug Interact; 2000; 17(1-4):3-22. PubMed ID: 11201301
[TBL] [Abstract][Full Text] [Related]
7. Chemoprevention by inducers of carcinogen detoxication enzymes.
Kensler TW
Environ Health Perspect; 1997 Jun; 105 Suppl 4(Suppl 4):965-70. PubMed ID: 9255588
[TBL] [Abstract][Full Text] [Related]
8. Molecular dosimetry of urinary aflatoxin-N7-guanine and serum aflatoxin-albumin adducts predicts chemoprotection by 1,2-dithiole-3-thione in rats.
Groopman JD; DeMatos P; Egner PA; Love-Hunt A; Kensler TW
Carcinogenesis; 1992 Jan; 13(1):101-6. PubMed ID: 1733561
[TBL] [Abstract][Full Text] [Related]
9. Transient intervention with oltipraz protects against aflatoxin-induced hepatic tumorigenesis.
Bolton MG; Muñoz A; Jacobson LP; Groopman JD; Maxuitenko YY; Roebuck BD; Kensler TW
Cancer Res; 1993 Aug; 53(15):3499-504. PubMed ID: 8339253
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of chemoprotection by oltipraz.
Kensler T; Styczynski P; Groopman J; Helzlsouer K; Curphey T; Maxuitenko Y; Roebuck BD
J Cell Biochem Suppl; 1992; 16I():167-72. PubMed ID: 1305682
[TBL] [Abstract][Full Text] [Related]
11. Protection against aflatoxin B1-induced hepatocarcinogenesis in F344 rats by 5-(2-pyrazinyl)-4-methyl-1,2-dithiole-3-thione (oltipraz): predictive role for short-term molecular dosimetry.
Roebuck BD; Liu YL; Rogers AE; Groopman JD; Kensler TW
Cancer Res; 1991 Oct; 51(20):5501-6. PubMed ID: 1680553
[TBL] [Abstract][Full Text] [Related]
12. Oltipraz chemoprevention trial in Qidong, People's Republic of China: modulation of serum aflatoxin albumin adduct biomarkers.
Kensler TW; He X; Otieno M; Egner PA; Jacobson LP; Chen B; Wang JS; Zhu YR; Zhang BC; Wang JB; Wu Y; Zhang QN; Qian GS; Kuang SY; Fang X; Li YF; Yu LY; Prochaska HJ; Davidson NE; Gordon GB; Gorman MB; Zarba A; Enger C; Muñoz A; Helzlsouer KJ
Cancer Epidemiol Biomarkers Prev; 1998 Feb; 7(2):127-34. PubMed ID: 9488587
[TBL] [Abstract][Full Text] [Related]
13. Oltipraz: clinical opportunities for cancer chemoprevention. p.
Kensler TW; Helzlsouer KJ
J Cell Biochem Suppl; 1995; 22():101-7. PubMed ID: 8538185
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional control of glutathione S-transferase gene expression by the chemoprotective agent 5-(2-pyrazinyl)-4-methyl-1,2-dithiole-3-thione (oltipraz) in rat liver.
Davidson NE; Egner PA; Kensler TW
Cancer Res; 1990 Apr; 50(8):2251-5. PubMed ID: 2317812
[TBL] [Abstract][Full Text] [Related]
15. Role of phase 2 enzyme induction in chemoprotection by dithiolethiones.
Kwak MK; Egner PA; Dolan PM; Ramos-Gomez M; Groopman JD; Itoh K; Yamamoto M; Kensler TW
Mutat Res; 2001 Sep; 480-481():305-15. PubMed ID: 11506823
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the cancer chemopreventive potency of dithiolethione analogs of oltipraz.
Roebuck BD; Curphey TJ; Li Y; Baumgartner KJ; Bodreddigari S; Yan J; Gange SJ; Kensler TW; Sutter TR
Carcinogenesis; 2003 Dec; 24(12):1919-28. PubMed ID: 14555609
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of aflatoxin Ml excretion in rat urine during dietary intervention with oltipraz.
Scholl P; Musser SM; Kensler TW; Groopman JD
Carcinogenesis; 1996 Jun; 17(6):1385-8. PubMed ID: 8681461
[TBL] [Abstract][Full Text] [Related]
18. Protective alterations in phase 1 and 2 metabolism of aflatoxin B1 by oltipraz in residents of Qidong, People's Republic of China.
Wang JS; Shen X; He X; Zhu YR; Zhang BC; Wang JB; Qian GS; Kuang SY; Zarba A; Egner PA; Jacobson LP; Muñoz A; Helzlsouer KJ; Groopman JD; Kensler TW
J Natl Cancer Inst; 1999 Feb; 91(4):347-54. PubMed ID: 10050868
[TBL] [Abstract][Full Text] [Related]
19. Chemopreventive effect of oltipraz during different stages of experimental colon carcinogenesis induced by azoxymethane in male F344 rats.
Rao CV; Rivenson A; Katiwalla M; Kelloff GJ; Reddy BS
Cancer Res; 1993 Jun; 53(11):2502-6. PubMed ID: 8495412
[TBL] [Abstract][Full Text] [Related]
20. Cancer chemoprotection by oltipraz: experimental and clinical considerations.
Helzlsouer KJ; Kensler TW
Prev Med; 1993 Sep; 22(5):783-95. PubMed ID: 8234218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
